Vape Game LLC
Letter data
- Company
- Vape Game LLC
- Recipient
- Dalton Baarstad, Terri Baarstad, Taylor Jones, and Ben Sandreth | Vape Game LLC | 120 Cleveland St. | Ste 4 | Eugene | , | OR | 97402 | United States | taylor@vape-game.com | dalton@vape-game.com | wholesale@vape-game.com | vapegamelabs@gmail.com | ben@vape-game.com
- Issue date
- 2020-08-10
- Posted date
- Not available
- FDA office
- Center for Tobacco Products
- Subject
- Not available
- Product
- Not available
- CMS ID
- 607462
- Reference number
- RW2001297
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Vape Game LLC
MARCS-CMS 607462 —
August 10, 2020
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA UPS and Electronic Mail
Reference #:
RW2001297
Recipient:
Recipient Name
Dalton Baarstad, Terri Baarstad, Taylor Jones, and Ben Sandreth
Vape Game LLC
120 Cleveland St.
Ste 4
Eugene
,
OR
97402
United States
taylor@vape-game.com
dalton@vape-game.com
wholesale@vape-game.com
vapegamelabs@gmail.com
ben@vape-game.com
Issuing Office:
Center for Tobacco Products
United States
Dear Dalton Baarstad, Terri Baarstad, Taylor Jones, and Ben Sandreth:
The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your responses, dated April 30, 2020 and July 31, 2020, in response to our Warning Letter dated April 22, 2020. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website https://vapegame.com.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.
Sincerely,
/S/
David Rice
Branch Chief
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products
Content current as of:
11/05/2020